CVE-2023-41088
Cleartext Transmission of Sensitive Information in DEXMA DEXGate
The affected product is vulnerable to a cleartext transmission of sensitive information vulnerability, which may allow an attacker with access to the network, where clients have access to the DexGate server, could capture traffic. The attacker can later us the information within it to access the application.
Attack profile
How easy it is to exploit
- Attack vector
- Adjacent network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- Required
What an attacker can affect
- Confidentiality
- High
- Integrity
- Low
- Availability
- None
Exploit likelihood
What each source reports
CVE List Score used
Cleartext Transmission of Sensitive Information in DEXMA DEXGate
The affected product is vulnerable to a cleartext transmission of sensitive information vulnerability, which may allow an attacker with access to the network, where clients have access to the DexGate server, could capture traffic. The attacker can later us the information within it to access the application.
- Record
CVE-2023-41088- CVSS 3.1
- 6.3 Medium
CVSS:3.1/AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:L/A:N - Weakness
- CWE-319
- Updated
- 2026-11-02
EUVDEUVD-2023-45608
The affected product is vulnerable to a cleartext transmission of sensitive information vulnerability, which may allow an attacker with access to the network, where clients have access to the DexGate server, could capture traffic. The attacker can later us the information within it to access the application.
- Record
EUVD-2023-45608- CVSS 3.1
- 6.3 Medium
CVSS:3.1/AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:L/A:N - Updated
- 2026-11-03
GitHub AdvisoriesGHSA-wxgq-cmv5-57qx
The affected product is vulnerable to a cleartext transmission of sensitive...
The affected product is vulnerable to a cleartext transmission of sensitive information vulnerability, which may allow an attacker with access to the network, where clients have access to the DexGate server, could capture traffic. The attacker can later us the information within it to access the application.
- Record
GHSA-wxgq-cmv5-57qx- CVSS 3.1
- 6.3 Medium
CVSS:3.1/AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:L/A:N - Weakness
- CWE-319
- Updated
- 2026-11-02
NVD
The affected product is vulnerable to a cleartext transmission of sensitive information vulnerability, which may allow an attacker with access to the network, where clients have access to the DexGate server, could capture traffic. The attacker can later us the information within it to access the application.
- Record
CVE-2023-41088- CVSS 3.1
- 6.3 Medium
CVSS:3.1/AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:L/A:N - CVSS 3.1
- 6.5 Medium
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N - Weakness
- CWE-319
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases, published | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2023-41088 is a medium vulnerability (CVSS 6.3) in Dexma Dexgate, published October 19, 2023. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.29%, the 21st percentile. No source names a fixed version.